Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis

Neurology

Volumn 37, Issue 4, 1987, Pages 693-695

  Poirier, G ^a   Montplaisir, J ^a   Dumont, M ^a   Duquette, P ^b   Decary, F ^c   Pleines, J ^b   Lamoureux, G ^d  

^a Centre d'Etude du Sommeil   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

^c Croix Rouge canadienne   (Canada)

^d INRS INSTITUT ARMAND FRAPPIER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATAPLEXY; CENTRAL NERVOUS SYSTEM; DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NARCOLEPSY; PARASOMNIA; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; SLEEP ATTACK;

ADULT; FEMALE; HLA-DR ANTIGENS; HLA-DR2 ANTIGEN; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NARCOLEPSY; QUESTIONNAIRES; SLEEP, REM;

EID: 0023115928     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.37.4.693     Document Type: Article

References (15)

1. Ekbom K. Familial multiple sclerosis associated with narcolepsy. Arch Neurol 1966;15:337-344.
2. Berg O, Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurol Scand 1963;39:252-257.
3. Bonduelle M, Degos C. Symptomatic narcolepsies: a critical study. In: Guilleminault C, Dement WC, Passouant P, eds. Narcolepsy. New York: Spectrum Publications, 1976:322-325.
4. Schrader H, Gotlibsen OB, Skomedal GN. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980;30:105-108.
5. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. Tissue Antigens 1984;24:316-319.
6. Langdon N, Van Dam M, Welsh KI, Vaughan RW, Parkes D. Genetic markers in narcolepsy. Lancet 1984;2:1178-1180.
7. Billiard M, Seignalet J. Extraordinary association between HLA-DR2 and narcolepsy. Lancet 1985;1:226-227.
8. Poirier G, Montplaisir J, Lebrun A, Decary F. HLA antigens in narcolepsy and idiopathic CNS hypersomnolence. Sleep 1986;9:153-158.
9. Duquette P, Decary F, Pleines J, et al. Clinical sub-groups of multiple sclerosis in relation to HLA: DR alleles as possible markers of disease progression. Can J Neurol Sci 1985;12:106-110.
10. Govaerts A, Gony J, Martin-Mondiere C, et al. HLA and multiple sclerosis: population and families study. Tissue Antigens 1985;25:187-199.
11. Cohen D, Le Gall I, Marcadet A, Font MP, Lanouel JM, Dausset J. Clusters of HLA class II B restriction fragments describe allelic series. Proc Natl Acad Sci USA 1984;81:7870-7874.
12. Marcadet A, Gebuhrer L, Betuel H, et al. DNA polymorphism related to HLA-DR2 Dw2 in patients with narcolepsy. Immuno-genetics 1985;22:679-683.
13. Marcadet A, Massart C, Semana G, et al. Association of class II HLA-DQB chain DNA restriction fragments with multiple sclerosis. Immunogenetics 1985;22:93-96.
14. Mitler MM. The multiple sleep latency test as an evaluation for excessive daytime somnolence. In: Guilleminault C, ed. Sleeping and waking disorders: indications and technique. Palo Alto, CA: Addison-Wesley Publishing, 1982:145-153.
15. Richardson GS, Carskadon MA, Flagg W, Van Den Hoed J, Dement WC, Mitler MM. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr Clin Neurophysiol 1978;45:621-627.